Age, outcomes, and treatment effects of fibrinolytic and antithrombotic combinations: findings from Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT)-3 and ASSENT-3 PLUS. [electronic resource]
Producer: 20061018Description: 684.e1-9 p. digitalISSN:- 1097-6744
- Aged
- Aged, 80 and over
- Aging
- Dose-Response Relationship, Drug
- Drug Therapy, Combination
- Female
- Fibrinolytic Agents -- administration & dosage
- Hemorrhage -- etiology
- Humans
- Male
- Middle Aged
- Myocardial Infarction -- complications
- Odds Ratio
- Randomized Controlled Trials as Topic
- Risk Assessment
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.